Accelerate diagnostics, inc. (AXDX)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Oct'12Sep'12Jun'12Apr'12Mar'12Jan'12Dec'11Oct'11Jul'11Apr'11Jan'11Oct'10
Product revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

76

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Technical development fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-247

-

-462

-

-772

-842

0

0

0

Licensing and royalty revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

128

128

122

122

55

52

46

48

38

41

56

49

226

227

233

0

204

0

221

34

34

0

0

0

Net sales

9,889

9,297

7,649

6,733

6,619

5,670

5,968

5,441

4,448

4,177

2,096

1,292

613

246

229

297

296

147

204

128

122

122

55

52

46

48

48

41

56

49

42

37

233

0

312

0

543

856

1,121

0

0

0

License fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-50

-

-50

-

-50

0

0

0

0

Qualified discovery therapeutic grant

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

-

0

-

0

244

0

0

0

Cost of sales

5,268

4,897

4,238

3,801

3,611

3,187

2,539

2,050

1,468

1,002

352

161

26

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gross profit

4,621

4,400

3,411

2,932

3,008

2,483

3,429

3,391

2,980

3,175

1,744

1,131

587

246

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Costs and expenses:
Research and development

24,254

25,345

26,051

27,878

27,789

27,638

26,868

25,328

24,795

22,301

21,756

23,279

26,177

29,564

31,761

30,386

29,087

27,142

24,806

24,256

21,692

19,526

17,750

14,456

12,355

10,673

7,562

6,120

3,763

1,979

892

461

365

0

371

0

399

448

454

0

0

0

Sales, general and administrative

52,106

51,886

51,681

51,091

53,584

55,214

53,307

52,755

48,885

45,058

44,060

42,025

40,049

37,183

33,310

28,076

23,347

18,554

14,533

12,826

11,518

10,695

9,513

7,940

5,727

4,312

2,549

3,130

2,894

2,428

3,249

2,897

1,723

0

936

0

956

1,043

819

0

0

0

Amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

23

38

54

71

76

77

77

77

82

76

121

166

164

139

192

0

191

0

191

254

253

0

0

0

Marketing and sales

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

0

0

-

0

-

0

0

0

Depreciation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,476

1,262

1,009

817

630

463

384

286

192

112

41

6

3

2

2

0

2

0

2

2

2

0

0

0

Impairment of intangibles

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

0

0

-

-

-

-

Total costs and expenses

76,360

77,231

77,732

78,969

81,373

82,852

80,175

78,083

73,680

67,359

65,816

65,304

66,226

66,747

63,869

57,728

52,106

45,696

40,841

38,385

34,276

31,112

27,980

22,947

18,554

15,359

11,846

9,771

7,154

4,914

6,641

3,497

2,284

0

1,495

0

1,543

1,746

1,530

0

0

0

Loss from operations

-71,739

-72,831

-74,321

-76,037

-78,365

-80,369

-76,746

-74,692

-70,700

-64,184

-64,072

-64,173

-65,639

-66,501

-63,640

-57,431

-51,810

-45,549

-40,637

-38,257

-34,154

-30,990

-27,925

-22,895

-18,508

-15,311

-11,801

-9,730

-7,097

-4,864

-6,598

-3,460

-2,050

0

-1,183

0

-999

-889

-409

0

0

0

Other income (expense):
Interest expense

-13,966

-14,256

-6,248

-6,489

-6,812

-10,113

6,720

3,363

158

0

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Foreign currency exchange loss

-193

-124

-261

-305

-564

-450

-333

-240

6

-75

-35

-37

-147

-77

-135

-92

25

-19

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

2,347

2,809

3,192

3,424

3,386

2,845

2,279

1,694

1,073

908

753

589

576

494

373

235

113

74

69

63

61

64

58

45

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-11

0

-

0

0

-

0

-

0

0

-

-

-

-

-

-

-

-

-

Other income, net

-

-

-

-

-

-

-

-

-

-

0

-

406

-

238

142

135

51

64

56

53

57

0

0

0

-

-

-

7

8

38

7

7

0

7

0

9

16

16

0

0

0

Other expense, net

94

14

15

6

30

28

30

0

0

-

-

0

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total other expense, net

-12,486

-11,585

-11,062

-10,624

-10,622

-7,746

-4,808

-2,085

0

-

0

0

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss before income taxes

-84,216

-84,416

-85,412

-86,663

-88,987

-88,115

-81,726

-76,805

-69,963

-63,535

-64,811

-65,647

0

-

0

0

-

-

-

-

-

-

-

-

-

-15,282

0

0

0

-

0

-1,937

59

0

20

12

-

13

30

0

0

0

Unrealized holding gain on asset sale

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

0

-

-

Gain on sale of equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

0

-

Net loss before income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Provision for income taxes

-332

-111

-183

164

248

211

705

603

677

493

220

175

0

-

0

0

-

-

-

-

-

0

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-83,893

-84,305

-85,161

-86,825

-89,235

-88,326

-82,431

-77,408

-70,640

-64,028

-63,867

-64,091

-65,500

-66,374

-63,402

-57,289

-51,675

-45,498

-41,100

-38,728

-34,628

-30,933

-27,327

-22,310

-17,935

-15,282

-11,788

-9,726

-7,072

-4,823

-6,545

-5,416

-2,010

0

-1,182

0

-1,006

-876

-378

0

0

0

Basic and diluted net loss per share (usd per share)

-0.39

-0.40

-0.37

-0.38

-0.40

-0.41

-0.41

-0.43

-0.37

-0.29

-0.31

-0.31

-0.27

-0.31

-0.34

-0.35

-0.29

-0.29

-0.25

-0.27

-0.20

-0.20

-0.20

-0.19

-0.12

-0.12

-0.10

-0.10

-0.09

0.02

-0.07

-0.15

-0.09

-0.03

-0.03

-0.03

-0.01

-0.04

-0.04

-0.01

0.00

0.01

Weighted average shares outstanding (shares)

54,837

54,658

54,553

54,476

54,337

54,188

54,145

54,003

55,640

55,521

55,316

53,568

51,887

51,456

51,239

51,213

51,196

45,937

44,727

44,678

44,650

174,374

44

43

41

150,288

39

38

29

25,703

25,261

25,004

11,776

11,103

11,103

11,103

11,160

11,103

10,946

10,704

10,757

10,757

Other comprehensive loss:
Net loss

-83,893

-84,305

-85,161

-86,825

-89,235

-88,326

-82,431

-77,408

-70,640

-64,028

-63,867

-64,091

-65,500

-66,374

-63,402

-57,289

-51,675

-45,498

-41,100

-38,728

-34,628

-30,933

-27,327

-22,310

-17,935

-15,282

-11,788

-9,726

-7,072

-4,823

-6,545

-5,416

-2,010

0

-1,182

0

-1,006

-876

-378

0

0

0

Net unrealized gain on debt securities available-for-sale

295

193

306

297

197

23

-178

-186

-181

-117

-68

-131

-105

-64

-5

64

27

-20

-8

-24

-14

-15

0

28

26

22

11

0

17

33

14

37

33

0

-21

0

-31

-18

0

0

0

0

Foreign currency translation adjustment

-41

-102

-206

-119

-360

-172

-135

-18

377

321

231

132

-23

-128

-5

1

-48

1

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comprehensive loss

-83,639

-84,214

-85,061

-86,647

-89,398

-88,475

-82,744

-77,612

-70,444

-63,824

-63,704

-64,090

-65,628

-66,566

-63,412

-57,224

-51,696

-45,517

-41,110

-38,752

-34,642

-30,948

-27,327

-22,282

-17,909

-15,260

0

-9,726

0

0

-

0

-

-

-

-

-

-

-

-

-

-